Learn more →
Back to Expert Scholars
hematopoietic-transplant / hematopoietic-transplantAllogeneic Stem Cell Transplantation

Joseph H. Antin

约瑟夫·安廷

MD

🏢Dana-Farber Cancer Institute / Brigham and Women's Hospital(丹娜-法伯癌症研究所/布莱根妇女医院)🌐USA

Chief Emeritus, Stem Cell Transplantation Program; Professor of Medicine, Harvard Medical School干细胞移植项目名誉主任,哈佛医学院医学教授

68
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Joseph Antin is a pioneer in hematopoietic stem cell transplantation at Dana-Farber and Brigham and Women's Hospital, with foundational contributions to GvHD biology and management, transplant-related complications, and aplastic anemia therapy spanning four decades. He has mentored generations of transplant physicians.

Share:

🧪Research Fields 研究领域

GvHD Management移植物抗宿主病管理
Transplant Complications移植并发症
HSCT造血干细胞移植
Bone Marrow Failure骨髓衰竭

🎓Key Contributions 主要贡献

GvHD Pathophysiology and Treatment

Made seminal discoveries in acute and chronic GvHD mechanisms and led clinical trials of novel immunosuppressive regimens that defined standards of care.

Aplastic Anemia Transplantation

Advanced allogeneic transplant as curative therapy for severe aplastic anemia, optimizing conditioning and donor selection to minimize rejection and GvHD.

Transplant Complication Management

Pioneered systematic approaches to transplant-related toxicities including veno-occlusive disease, infectious complications, and organ dysfunction.

Representative Works 代表性著作

[1]

Recombinant human interleukin-11 for the treatment of thrombocytopenia after autologous bone marrow transplantation

Blood (1994)

Demonstrated clinical efficacy of IL-11 for managing post-transplant thrombocytopenia.

[2]

Establishment and results of a modified standard graft-versus-host disease prophylaxis program at Dana-Farber Cancer Institute

Biology of Blood and Marrow Transplantation (2002)

Defined an institutional GvHD prophylaxis protocol with outcomes influencing national practice.

[3]

Graft-versus-leukemia reactions after bone marrow transplantation

Blood (1999)

Reviewed mechanisms and clinical evidence for GvL effects, framing the therapeutic rationale for allogeneic transplant.

🏆Awards & Recognition 奖项与荣誉

🏆E. Donnall Thomas Award, American Society for Transplantation and Cellular Therapy
🏆Lifetime Achievement Award, Dana-Farber Cancer Institute
🏆Harvard Medical School Dean's Award for Teaching

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 约瑟夫·安廷 的研究动态

Follow Joseph H. Antin's research updates

留下邮箱,当我们发布与 Joseph H. Antin(Dana-Farber Cancer Institute / Brigham and Women's Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment